Comparison Of Igf-1 Protein Expression As A Marker For Type I Collagen Production in The Uterosacral Ligament Of Patients With Uterine Prolapse and without Uterine Prolapse to Prevent Uterine Prolapse

Kania Praharsini; R. M. Sonny Sasotya; M. Rizkar Arev Sukarsa

doi:10.24198/obgynia.v8i1.773

Comparison Of Igf-1 Protein Expression As A Marker For Type I Collagen Production in The Uterosacral Ligament Of Patients With Uterine Prolapse and without Uterine Prolapse to Prevent Uterine Prolapse

Kania Praharsini, R. M. Sonny Sasotya, M. Rizkar Arev Sukarsa

Abstract

Objective: This study aims to investigate the risk factors associated with the lower IGF-1 protein expression in the uterosacral ligament in relation to the incidence of uterine prolapse. By identifying the relationship between IGF-1 protein expression in the uterosacral ligament and the incidence of uterine prolapse, it is anticipated that this study will provide a basis for the early identification of uterine prolapse.
Method: This study utilized a cross-sectional immunohistochemistry method for IGF-1 protein on 34 pelvic organ prolapse (POP) subjects and 34 controls at RSUP Dr. Hasan Sadikin, Bandung, in 2024. A sample is taken from the distal portion of the uterosacral ligament, prepared into paraffin blocks and underwent immunochemistry staining. It was then reviewed and IGF-1 protein expression graded by a consultant pathologist.
Results: IGF-1 protein expression in the uterosacral ligament was found to be lower in uterine prolapse patients (168.2 + 3.1) compared to those without uterine prolapse (181.2 + 13.3) (p=0.002).
Conclusion: IGF-1 levels in uterine prolapse are lower than those without uterine prolapse.

Perbandingan Ekspresi Protein IGF-1 sebagai Penanda Produksi Kolagen Tipe I pada Ligamentum Sakrouterina Penderita Prolaps Uterus dan Tanpa Prolaps Uterus untuk Pencegahan Prolaps Uterus

Abstrak
Tujuan: Penelitian ini bertujuan untuk meneliti faktor risiko rendahnya ekspresi protein IGF-1 pada ligamentum sakrouterina terhadap kejadian prolaps uterus. Dengan diketahui adanya hubungan antara ekspresi protein IGF-1 pada ligamentum sakrouterina dengan terjadinya prolaps uterus, diharapkan penelitian ini dapat berguna sebagai acuan untuk identifikasi prolaps uterus lebih dini.
Metode: Penelitian ini menggunakan metode potong lintang imunohistokimia protein IGF-1 pada 34 subjek prolaps organ panggul (POP) dan 34 kontrol di RS Dr. Hasan Sadikin Bandung tahun 2024. Sampel diambil dari bagian distal ligamentum sakrouterina, dibuat blok paraffin, dan dilakukan pewarnaan histokimia. Ekspresi protein IGF-1 kemudian diperiksa dan dinilai oleh ahli patologi.
Hasil: Ekspresi protein IGF-1 di ligamentum sakrouterina pada penderita prolaps uterus lebih rendah (168,2 + 3,1) dibandingkan dengan tanpa prolaps uterus (181,2 + 13,3) (p=0,002).
Kesimpulan: Kandungan IGF-1 pada prolaps uterus lebih rendah dibandingkan dengan tanpa prolaps uterus.

Kata kunci: IGF-1, kolagen tipe I, ligamentum sakrouterina, prolaps uterus

Full Text:

PDF

References

Ilunga-Mbaya E, Mukwege D, Tshilobo PL, Maroyi KR, Tozin RR, Mushengezi DS. Pelvic organs prolapse in low-resources countries: Epidemiology, risk factors, quality of life. Narrative review. Op J Uro. 2023;13.

Chen CJ, Thompson H. Uterine prolapse. 2022 [Diunduh tanggal 26 October 2024; Tersedia dari: https://www.ncbi.nlm.nih.gov/books/NBK564429/

Devkota HR, Sijali TR, Harris C, Ghimire DJ, Prata N, Bates MN. Bio-mechanical risk factors for uterine prolapse among women living in the hills of west Nepal: A case-control study. Women’s Health. 2020;16:doi:10.1177/1745506519895175.

Departemen Obstetri dan Ginekologi Unpad. Laporan tahunan obstetri dan ginekologi RSHS 2022. Bandung: Universitas Padjadjaran 2022.

Putra IGM, Warsita IGN, Suwiyoga K, Manuaba IBGF, Budiana ING, Wiradnyana AAGP. Low expression of collagen type-1 in sacrouterine ligament as risk factor of stage III–IV uterine prolapse. Eur J Obst Gynecol Reprod Biol. 2020;249:32-6.

Salvatore S, Bastiani SD, Deo FD. Epidemiology and etiology of pelvic organ prolapse. Dalam: Santoro GA, Wieczorek AP, Sultan AH, penyunting. Pelvic floor disorders. Edisi ke-2. Philadelphia: Springer. 2021: hlm. 547–54.

Petros P. The integral system. Cent European J Urol. 2011;64(3):110-9.

Hu C, Santi M, Adelaja O, Balla AK, Popescu G, Kobak W. Imaging collagen properties in the uterosacral ligaments of women with pelvic organ prolapse using spatial light interference microscopy (SLIM). 2019 [Diunduh tanggal 26 Oktober 2024]; Tersedia dari: https://www.frontiersin.org/journals/physics/articles/10.3389/fphy.2019.00072/full#B3

Bailey AJ. Molecular mechanisms of ageing in connective tissues. Mech Ageing Dev. 2001;122:735-55.

Kerkhof MH, Hendriks L, Brölmann HAM. Changes in connective tissue in patients with pelvic organ prolapse—a review of the current literature. Int Urogynecol J. 2009;20:461-74.

Yin Y, Qin M, Luan M, Xia Z. miR-19-3p promotes autophagy and apoptosis in pelvic organ prolapse through the AKT/mTOR/p70S6K pathway: Function of miR-19-3p on vaginal fibroblasts by targeting IGF-1. Female Pelvic Med Reconstr Surg. 2021;27:e630-e8.

Tzanakakis GN, Giatagana EM, Berdiaki A, Spyridaki I, Hida K, Neagu M, dkk. The role of IGF/IGF-IR-signaling and extracellular matrix effectors in bone sarcoma pathogenesis. Cancers. 2021;13:2478.

Yin Y, Han Y, Shi C, Xia Z. IGF-1 regulates the growth of fibroblasts and extracellular matrix deposition in pelvic organ prolapse. Open Med. 2020;15:833-40.

Cizkova K, Foltynkova T, Gachechiladze M, Tauber Z. Comparative analysis of immunohistochemical staining intensity determined by light microscopy, imagej and qupath in placental hofbauer cells. Acta Histochem Cytochem. 2021;54(1):21-9.

Weintraub AY, Glinter H, Marcus-Braun N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int Braz J Urol. 2020;46:5-14.

Bai SW, Choe BH, Kim JY, Park KH. Pelvic organ prolapse and connective tissue abnormalities in Korean women. J Reprod Med. 2002;47(3):231-4.

Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, dkk. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014;123:141-8.

Sayko SK, Kurniawati EM, Lestari P. Age as the risk factor that affected the increased degree of uterine prolapse. Biomolecular Health Sci J. 2018;1(1):20-5.

Swift S, Woodman P, O'Boyle A, Kahn M, Valley M, Bland D, dkk. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol. 2005;192(3):795-806.

Bradley CS, Zimmerman MB, Qi Y, Nygaard IE. Natural history of pelvic organ prolapse in postmenopausal women. Obstet Gynecol. 2007;109(4):848-54.

Yucel N, Usta A, Guzin K, Kanter M, Bilgic E, Ozel NO, dkk. Immunohistochemical analysis of connective tissue in patients with pelvic organ prolapse. J Mol Histol. 2013;44(1):97-102.

Chetty A, Cao GJ, Nielsen H. Insulin-like Growth Factor-I signaling mechanisms, type I collagen and alpha smooth muscle actin in human fetal lung fibroblasts. Pediatr Res. 2006;60(4):389-94.

Ozbek E, Otunctemur A, Sahin S, Ozcan L, Dursun M, Polat E, dkk. Low serum Insulin Like Growth Factor - 1 in patients with Stress Urinary Incontinence. Int Braz J Urol. 2016;42(4):787-92.

Provenzano PP, Alejandro-Osorio AL, Grorud KW, Martinez DA, Vailas AC, Grindeland RE, dkk. Systemic administration of IGF-I enhances healing in collagenous extracellular matrices: evaluation of loaded and unloaded ligaments. BMC Physiol. 2007;7(2):2.

Yan H, Zhong L, Jiang Y, Yang J, Deng J, Wei S, dkk. Controlled release of insulin-like growth factor 1 enhances urethral sphincter function and histological structure in the treatment of female stress urinary incontinence in a rat model. BJU Int. 2018;121(2):301-12.

DOI: http://dx.doi.org/10.24198/obgynia.v8i1.773